Condition
Plasmapheresis
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting1
Terminated1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05562960Not ApplicableRecruiting
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP
NCT05004220Completed
Effects of Plasmapheresis on Aging Biomarkers
NCT05815615Not ApplicableCompletedPrimary
Plasmapheresis: a Multi-modal Approach
NCT00001349Terminated
Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
NCT03965559Completed
The Efficacy of Plasmapheresis and Double Filtration Plasmapheresis (DFPP) in Kidney Transplant
NCT00203281Withdrawn
Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
Showing all 6 trials